Literature DB >> 6120949

No response of pancreatic hormones to hypoglycemia in diabetic autonomic neuropathy.

J Hilsted, S Madsbad, T Krarup, B Tronier, H Galbo, L Sestoft, T W Schwartz.   

Abstract

The responses of pancreatic hormones (i.e. glucagon, pancreatic polypeptide, and somatostatin) to insulin-induced hypoglycemia were investigated in 18 insulin-dependent diabetics without residual beta-cell function and in 6 normal subjects. Nine of the diabetics had autonomic neuropathy, and 9 had no neuropathy. After hypoglycemia, no significant increase in any of the 3 pancreatic hormones was found in the diabetics with autonomic neuropathy, whereas significant increments were found in the diabetics without neuropathy and in the normal subjects. These results suggest that autonomic nervous activity is of major importance for pancreatic hormone release during hypoglycemia in man.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6120949     DOI: 10.1210/jcem-54-4-815

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Pancreatic polypeptide secretion after insulin infusion and protein meal in juvenile type 1 diabetic subjects.

Authors:  M Carrà; P Brambilla; F Meschi; L Mistura; E Bognetti; A Malesci; C Bonato; P Bocchia; G Chiumello
Journal:  Acta Diabetol Lat       Date:  1990 Apr-Jun

Review 2.  Endogenous somatostatin and the gut.

Authors:  M R Lucey
Journal:  Gut       Date:  1986-04       Impact factor: 23.059

3.  Carbohydrate digestion and release of pancreatic polypeptide in health and diabetes mellitus.

Authors:  P Layer; V L Go; E P DiMagno
Journal:  Gut       Date:  1989-09       Impact factor: 23.059

4.  Effects of chronic sodium salicylate feeding on the impaired glucagon and epinephrine responses to insulin-induced hypoglycaemia in streptozotocin diabetic rats.

Authors:  D G Patel; K A Skau
Journal:  Diabetologia       Date:  1989-01       Impact factor: 10.122

5.  Pancreatic polypeptide response to a protein-rich meal in diabetic patients with and without neuropathy.

Authors:  S Gambardella; M G Felici; B Annibale; G F Delle Fave; F Jacoangeli; V Spallone; G Menzinger
Journal:  J Endocrinol Invest       Date:  1986-02       Impact factor: 4.256

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.